Literature DB >> 8696780

Identification of antioxidants for prevention of peroxide-mediated oxidation of recombinant human ciliary neurotrophic factor and recombinant human nerve growth factor.

V M Knepp1, J L Whatley, A Muchnik, T S Calderwood.   

Abstract

Peroxides present in non-ionic surfactants used to stabilize certain recombinant protein formulations (e.g. polysorbate 80) can result in the oxidative degradation of proteins. In this study, the ability of various pharmaceutically acceptable antioxidants to prevent the oxidative degradation of two therapeutic proteins, recombinant human Ciliary Neurotrophic Factor (rhCNTF) and recombinant human Nerve Growth Factor (rhNGF), caused by alkyl hydroperoxides and hydrogen peroxide was studied. For rhCNTF, the rank order of effectiveness of the antioxidants tested was: thiols (cysteine, glutathione, thioglycerol) >> thioethers (methionine). Other parenterally acceptable antioxidants (ascorbic acid, propyl gallate and sodium bisulfite) destabilized the protein. The thiol antioxidants (cysteine and glutathione) were also the most effective antioxidants for rhNGF; however, in contrast to rhCNTF, ascorbic acid did not destabilize rhNGF. The rank order of effective antioxidants for rhNGF was: thiols (cysteine, glutathione) > > thioethers (methionine) > ascorbic acid.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8696780

Source DB:  PubMed          Journal:  PDA J Pharm Sci Technol        ISSN: 1079-7440


  14 in total

1.  Characterization of 5-fluorouracil microspheres for colonic delivery.

Authors:  Ziyaur Rahman; Kanchan Kohli; Roop K Khar; Mushir Ali; Naseem A Charoo; Areeg A A Shamsher
Journal:  AAPS PharmSciTech       Date:  2006-05-26       Impact factor: 3.246

2.  Stability of nonaqueous suspension formulations of plasma derived factor IX and recombinant human alpha interferon at elevated temperatures.

Authors:  V M Knepp; A Muchnik; S Oldmark; L Kalashnikova
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

Review 3.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

4.  Development of a stable low-dose aglycosylated antibody formulation to minimize protein loss during intravenous administration.

Authors:  Sorina Morar-Mitrica; Manasi Puri; Alexandra Beumer Sassi; Joshua Fuller; Ping Hu; George Crotts; Douglas Nesta
Journal:  MAbs       Date:  2015       Impact factor: 5.857

Review 5.  Physicochemical and formulation developability assessment for therapeutic peptide delivery--a primer.

Authors:  Annette Bak; Dennis Leung; Stephanie E Barrett; Seth Forster; Ellen C Minnihan; Andrew W Leithead; James Cunningham; Nathalie Toussaint; Louis S Crocker
Journal:  AAPS J       Date:  2014-11-15       Impact factor: 4.009

6.  Effect of polysorbate 80 quality on photostability of a monoclonal antibody.

Authors:  Swita R Singh; Jingming Zhang; Courtney O'Dell; Ming-Ching Hsieh; Joel Goldstein; Joseph Liu; Arvind Srivastava
Journal:  AAPS PharmSciTech       Date:  2012-02-24       Impact factor: 3.246

7.  Site-specific tryptophan oxidation induced by autocatalytic reaction of polysorbate 20 in protein formulation.

Authors:  Xanthe M Lam; William G Lai; Edwin K Chan; Victor Ling; Chung C Hsu
Journal:  Pharm Res       Date:  2011-06-08       Impact factor: 4.200

8.  Mechanism of Decarboxylation of Pyruvic Acid in the Presence of Hydrogen Peroxide.

Authors:  Antonio Lopalco; Gautam Dalwadi; Sida Niu; Richard L Schowen; Justin Douglas; Valentino J Stella
Journal:  J Pharm Sci       Date:  2016-01-29       Impact factor: 3.534

9.  Effect of Chemical Oxidation on the Higher Order Structure, Stability, Aggregation, and Biological Function of Interferon Alpha-2a: Role of Local Structural Changes Detected by 2D NMR.

Authors:  Dinen D Shah; Surinder M Singh; Krishna M G Mallela
Journal:  Pharm Res       Date:  2018-10-15       Impact factor: 4.200

10.  Melatonin alters the metabolism of the beta-amyloid precursor protein in the neuroendocrine cell line PC12.

Authors:  W Song; D K Lahiri
Journal:  J Mol Neurosci       Date:  1997-10       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.